Literature DB >> 33407713

Chromosome Y as a marker for sex discrepancies in patients with organ transplants: a case report.

Nuria Balaguer1, Emilia Mateu-Brull1, Roy P Naja2, Jara B Nagi3, Miguel Milán4.   

Abstract

BACKGROUND: Organ transplantations cause discrepancy in results from cell-free DNA (cfDNA) testing, but scientific literature is scarce. CASE: A 33-year old gravida underwent cfDNA testing, which showed high levels of Y chromosome (ChrY) in the maternal bloodstream. The ChrY pattern was comparable to an adult male reference. As a result, cfDNA testing was only informative for autosomes. Routine 20-week ultrasound scan showed no structural alterations and the presence of female external genitalia. Post-clinical research revealed that the patient received a bone marrow transplant from a male donor several years before. Fluorescence in situ hybridization showed that 100% of nuclei analysed from the patient's lymphocytes presented a ChrY.
CONCLUSION: This case demonstrates ChrY can be used as a marker to avoid sex discrepancies in certain patients with organ transplants.

Entities:  

Keywords:  Bone marrow; NIPT; Sex-discrepancy; cfDNA

Year:  2021        PMID: 33407713     DOI: 10.1186/s13039-020-00523-0

Source DB:  PubMed          Journal:  Mol Cytogenet        ISSN: 1755-8166            Impact factor:   2.009


  15 in total

1.  Determination of fetal DNA fraction from the plasma of pregnant women using sequence read counts.

Authors:  Sung K Kim; Gregory Hannum; Jennifer Geis; John Tynan; Grant Hogg; Chen Zhao; Taylor J Jensen; Amin R Mazloom; Paul Oeth; Mathias Ehrich; Dirk van den Boom; Cosmin Deciu
Journal:  Prenat Diagn       Date:  2015-06-03       Impact factor: 3.050

2.  Discrepancy in fetal sex assignment between cell free fetal DNA and ultrasound.

Authors:  J I Iruretagoyena; M Grady; D Shah
Journal:  J Perinatol       Date:  2015-03       Impact factor: 2.521

Review 3.  Implications of fetoplacental mosaicism on cell-free DNA testing: a review of a common biological phenomenon.

Authors:  F R Grati
Journal:  Ultrasound Obstet Gynecol       Date:  2016-10       Impact factor: 7.299

4.  Maternal liver transplant: Another cause of discordant fetal sex determination using cell-free DNA.

Authors:  Maria Neofytou; Nathalie Brison; Kris Van den Bogaert; Luc Dehaspe; Koen Devriendt; Anja Geerts; Joris R Vermeesch
Journal:  Prenat Diagn       Date:  2018-01-04       Impact factor: 3.050

Review 5.  Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis.

Authors:  Stephanie A Devaney; Glenn E Palomaki; Joan A Scott; Diana W Bianchi
Journal:  JAMA       Date:  2011-08-10       Impact factor: 56.272

6.  Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.

Authors:  H Zhang; Y Gao; F Jiang; M Fu; Y Yuan; Y Guo; Z Zhu; M Lin; Q Liu; Z Tian; H Zhang; F Chen; T K Lau; L Zhao; X Yi; Y Yin; W Wang
Journal:  Ultrasound Obstet Gynecol       Date:  2015-04-08       Impact factor: 7.299

7.  Single-nucleotide polymorphism-based noninvasive prenatal screening in a high-risk and low-risk cohort.

Authors:  Eugene Pergament; Howard Cuckle; Bernhard Zimmermann; Milena Banjevic; Styrmir Sigurjonsson; Allison Ryan; Megan P Hall; Michael Dodd; Phil Lacroute; Melissa Stosic; Nikhil Chopra; Nathan Hunkapiller; Dennis E Prosen; Sallie McAdoo; Zachary Demko; Asim Siddiqui; Matthew Hill; Matthew Rabinowitz
Journal:  Obstet Gynecol       Date:  2014-08       Impact factor: 7.661

Review 8.  Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis.

Authors:  Caroline F Wright; Yinghui Wei; Julian P T Higgins; Gurdeep S Sagoo
Journal:  BMC Res Notes       Date:  2012-09-01

Review 9.  Noninvasive Prenatal Testing - When Is It Advantageous to Apply.

Authors:  Thomas Liehr; Angela Lauten; Uwe Schneider; Ekkehard Schleussner; Anja Weise
Journal:  Biomed Hub       Date:  2017-03-04

10.  Fetal Sex Results of Noninvasive Prenatal Testing and Differences With Ultrasonography.

Authors:  Rupin Dhamankar; Wendy DiNonno; Kimberly A Martin; Zachary P Demko; Veronica Gomez-Lobo
Journal:  Obstet Gynecol       Date:  2020-05       Impact factor: 7.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.